Cargando…

PREEMPTIVE PHARMACOGENETIC TESTING: EXPLORING THE KNOWLEDGE AND PERSPECTIVES OF UNITED STATES PAYERS

PURPOSE: Preemptive pharmacogenetic testing aims to optimize medication use by having genetic information at the point of prescribing. Payers’ decisions influence implementation of this technology. We investigated U.S. payers’ knowledge, awareness, and perspectives on preemptive pharmacogenetic test...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keeling, Nicholas J., Rosenthal, Meagen M., West-Strum, Donna, Patel, Amit, Haidar, Cyrine E., Hoffman, James M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920773/ https://www.ncbi.nlm.nih.gov/pubmed/31048813 http://dx.doi.org/10.1038/gim.2017.181

Ejemplares similares

Multi-site investigation of strategies for the clinical implementation of preemptive pharmacogenetic testing
por: Duarte, Julio D., et al.
Publicado: (2021)

Development and use of active clinical decision support for preemptive pharmacogenomics
por: Bell, Gillian C, et al.
Publicado: (2014)

Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in patients
por: Del Re, Marzia, et al.
Publicado: (2015)

Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation
por: Lau-Min, Kelsey S., et al.
Publicado: (2022)

Geographic variation in cesarean delivery in the United States by payer
por: Henke, Rachel Mosher, et al.
Publicado: (2014)

Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underserved
por: Gawronski, Brian E., et al.
Publicado: (2023)

Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands
por: Bank, P. C. D., et al.
Publicado: (2019)

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
por: Caudle, Kelly E., et al.
Publicado: (2019)

The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge
por: Hernandez-Boussard, Tina, et al.
Publicado: (2008)

Pharmaceutical Technology Assessment: Perspectives from Payers
por: Leung, Musetta Y., et al.
Publicado: (2012)

From non-preemptive to preemptive scheduling using synchronization synthesis
por: Černý, Pavol, et al.
Publicado: (2016)

A cluster-randomized controlled knowledge translation feasibility study in Alberta community pharmacies using the PARiHS framework: study protocol
por: Rosenthal, Meagen M, et al.
Publicado: (2015)

Payer perceptions and use of value assessment tools in the United States
por: Westrich, Kimberly, et al.
Publicado: (2023)

Lessons from clinical implementation of a preemptive pharmacogenetic panel as part of a testing pilot program with an employer-sponsored medical plan
por: Norris, Madeline, et al.
Publicado: (2023)

Factors Influencing the Use of Second-Generation Antipsychotics in Children with Psychosis
por: Ramachandran, Sujith, et al.
Publicado: (2016)

Perioperative Comparison of Preemptive and Non-Preemptive Renal Transplant Recipients
por: Aytekin, Sami, et al.
Publicado: (2020)

Hospitals and the Tax-Payer
Publicado: (1920)

Preemptive analgesia in third molar impaction surgery
por: Shah, Rakesh, et al.
Publicado: (2012)

Overview of alopecia areata for managed care and payer stakeholders in the United States
por: King, Brett, et al.
Publicado: (2023)

Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research
por: Daud, Aizati N. A., et al.
Publicado: (2017)

Preemptive SARS patents
por: Brickley, Peg
Publicado: (2003)

A Private Payer Persective
por: Shurney, Dexter W.
Publicado: (2006)

Exploring Pharmacogenetic Testing for Hypertension Management in China
por: Zhao, Zhenping, et al.
Publicado: (2023)

Cost of hospitalization for firearm injuries by firearm type, intent, and payer in the United States
por: Peek-Asa, Corinne, et al.
Publicado: (2017)

Healthcare resource use and cost burden of urinary incontinence to United States payers
por: Datar, Manasi, et al.
Publicado: (2022)

Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians
por: Albitar, Lina, et al.
Publicado: (2021)

Variability in Private Payer Medical Policies for Osteochondral Allograft Transplantation Demonstrates the Absence of Standardization in Medical Criteria Between Payers
por: Tabbaa, Suzanne M., et al.
Publicado: (2022)

Treatment Patterns and Health Care Costs of Lupus Nephritis in a United States Payer Population
por: Bartels-Peculis, Laura, et al.
Publicado: (2020)

Preemptive Medicine for Cerebral Aneurysms
por: AOKI, Tomohiro, et al.
Publicado: (2016)

Non-Preemptive Tree Packing
por: Lendl, Stefan, et al.
Publicado: (2022)

All-payer ratesetting: Down but not out
por: Anderson, Gerard F.
Publicado: (1992)

Are payers treating orphan drugs differently?
por: Cohen, Joshua P., et al.
Publicado: (2014)

Payer-Negotiated Prices for Telemedicine Services
por: Wu, Shannon S., et al.
Publicado: (2022)

An integrated valuation model for payer and investor
por: Nuijten, Mark, et al.
Publicado: (2022)

Payer Perspectives on Health Technology Assessment
por: Watkins, John B.
Publicado: (2012)

Preemptive analgesia with Ketamine for Laparoscopic cholecystectomy
por: Singh, Harsimran, et al.
Publicado: (2013)

Employment and ability to work after kidney transplantation in the Netherlands: The impact of preemptive versus non‐preemptive kidney transplantation
por: Visser, Annemieke, et al.
Publicado: (2022)

Exploring HPV vaccination policy and payer strategies for opportunities to improve uptake in safety-net settings
por: Sloan, Kylie, et al.
Publicado: (2023)

Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
por: Pritchard, Daryl, et al.
Publicado: (2022)

The Professional Culture of Community Pharmacy and the Provision of MTM Services
por: Rosenthal, Meagen M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6rgqrtoeuml5v7gh2qk72ac45t